Publication: Patents:
- AI-Guided Design of EPR-Responsive Nanocarriers for Personalized Tumor-Targeted Chemotherapy", Patent Application No. 202641050244, published on 01-05-2026.
- AI-Driven Predictive andse Therapeutic Systems for Overcoming Immunotherapy Resistance in Colorectal Cancer Liver Metastases", Patent Application No. 202641050246, published on 01-05-2026.
- AI-Optimized CAR-T Cell Engineering Platforms for Personalized Immunotherapy", Patent Application No. 202641050247, published on 01-05-2026.
Books:
- Genomic Profiling for Precision Therapeutics ISBN No : 978-1-972547-57-1.
- Theranostics Imaging-Guided Nanotherapy ISBN No: 978-1-972547-55-7.
Publications:
- Machine Learning–Driven Symptom-Based Cancer Risk Stratification: A Systematic Review of Clinical Prediction Models and Methodological Rigor.
- Enhanced Predictive Analytics for Early Malignancy Discovery in Routine Screening.
- EVALUATING THE ASSOCIATION OF CANCER-RELATED RISK FACTORS WITH MULTISYSTEM HEALTH: INSIGHTS INTO FERTILITY, CARDIOVASCULAR, AND RENAL INDICATORS.
- From Prediction to Precision: An Externally Validated Deep Learning–Based Survival and Adjuvant Therapy Recommendation System for Resected Stage III Non–Small Cell Lung Cancer.
- IMMUNOTHERAPY AND CELL THERAPY: DEVELOPING CAR-T CELL THERAPIES AND OTHER IMMUNE-BASED TREATMENTS FOR CANCER AND AUTOIMMUNE DISEASES
|
International Journal of Science, Engineering and Technology